Effects of linagliptin on atherosclerotic progression in type 2 diabetics
Latest Information Update: 14 Dec 2018
Price :
$35 *
At a glance
- Drugs Linagliptin (Primary)
- Indications Atherosclerosis; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 14 Nov 2018 Results assessing long-term effects of linagliptin on atherosclerotic progression in patients with type-2 diabetes mellitus receiving statin (n=50) presented at the 91st Annual Scientific Sessions of the American Heart Association
- 15 Nov 2017 Results (n=30) presented at the 90th Annual Scientific Sessions of the American Heart Association
- 29 Jan 2014 New trial record